PreClinical CRO dedicated to your NonClinical projects
Pulmonary Arterial Hypertension (PAH) is an orphan disease, incurable that remains highly lethal despite recent advanced medical treatment.
Syncrosome invites you to visit us at Neuroconnection in Marseille the 1st and 2nd July. In the framework of the European project NeuroRescue, this symposium is an European event around technological innovation and private-public partnerships in NEUROSCIENCES and AGEING.
Diabetes is a chronic metabolic disorder, caused by a failure of the body to produce insulin and/or an inability of the body to respond adequately to circulating insulin. The WHO estimates that 346 million people worldwide have diabetes.
Is your company involved in the development of Cardiovascular, Respiratory, Gastroinestinal or Central Nervous System drugs? Are you considering to test new or existing products for the prevention and treatment of various disease?
Parc scientifique de Luminy
Case Postale 908
Luminy biotech entreprises
163, avenue de Luminy
13288 MARSEILLE cedex 09
Phone : +(33) 495 053 180
Web : www.syncrosome.com